Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants

Clinical trial NCT00779779 · COMPLETED

Trial details

NCT number: NCT00779779
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Infections, Rotavirus

Start date: 2008-11-22
Primary completion: 2009-05-25
Enrollment: 522

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.